Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Solid Tumors × Albumin-Bound Paclitaxel × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Pancreatic Neoplasms 3 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Solid Tumors 1 Sarcoma 1 Prostatic Neoplasms 1 Pancreatic Adenocarcinoma 1 Ovarian Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

spartalizumab 1 selicrelumab 1 fludarabine 1 Sunitinib 1 Sirolimus 1 Interleukin-2 1 Cyclophosphamide 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05648994 2022-12-13

TCR-T Cells for the Treatment NY-ESO-1-positive Advanced Solid Tumors

Fujian Cancer Hospital

Phase EARLY_PHASE1 Not yet recruiting

Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡